Breaking News

ProBioGen to Operate GMP Manufacturing Operation at Berlin Center for Gene & Cell Therapies

ProBioGen will oversee the design, lead the construction, and subsequently operate the 4,600-square-meter GMP manufacturing unit.

Author Image

By: Charlie Sternberg

Associate Editor

Groundbreaking of the BC GCT.

ProBioGen has been selected to operate the process development and good manufacturing practice (GMP) production facility for Advanced Therapy Medicinal Products (ATMPs) at the Berlin Center for Gene and Cell Therapies (BC GCT), a joint project of Charité –Universitätsmedizin Berlin, Bayer AG and Berlin Institute of Health at Charité (BIH). ProBioGen will oversee the design, lead the construction, and subsequently operate the 4,600-square-meter GMP manufacturing unit — an integral part of the ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters